HRJ

official impact factor 1.46

Open Access Research

Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States – Mexico border

Joan P Baumbach1*, Lily N Foster1, Mark Mueller1, Michelle F Cruz2, Sonia Arbona3, Sharon Melville3, Rebeca Ramos4 and Steffanie A Strathdee5

Author Affiliations

1 New Mexico Department of Health, Santa Fe, NM, USA

2 Centre for Addiction and Mental Health, Toronto, ON, Canada

3 Texas Department of State Health Services, Austin, TX, USA

4 United States – Mexico Border Health Association, El Paso, TX, USA

5 University of California, San Diego, CA, USA

For all author emails, please log on.

Harm Reduction Journal 2008, 5:33 doi:10.1186/1477-7517-5-33

Published: 16 November 2008

Abstract

Background

The region situated where the borders of Mexico, Texas and New Mexico meet is known as 'Paso del Norte'. The Paso del Norte Collaborative was formed to study the seroprevalence of select pathogens and associated risk behaviors among injection drug users (IDUs) in the region.

Methods

Respondent-driven sampling (RDS) was used: 459 IDU participants included 204 from Mexico; 155 from Texas; and 100 from New Mexico. Each of the three sites used a standardized questionnaire that was verbally administered and testing was performed for select bloodborne infections.

Results

Participants were mostly male (87.4%) and Hispanic/Latino (84.7%) whose median age was 38. In Mexico, Texas and New Mexico, respectively: hepatitis B virus (HBV) was seen in 88.3%, 48.6% and 59.6% of participants; hepatitis C virus (HCV) in 98.7%, 76.4% and 80.0%; human immunodeficiency virus (HIV) in 2.1%, 10.0% and 1.0%; and syphilis in 4.0%, 9.9% and 3.0%. Heroin was the drug injected most often. More IDUs in New Mexico were aware of and used needle exchange programs compared with Texas and Mexico.

Conclusion

There was mixed success using RDS: it was more successfully applied after establishing good working relationships with IDU populations. Study findings included similarities and distinctions between the three sites that will be used to inform prevention interventions.